1. Home
  2. LDOS vs RVMD Comparison

LDOS vs RVMD Comparison

Compare LDOS & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leidos Holdings Inc.

LDOS

Leidos Holdings Inc.

HOLD

Current Price

$149.14

Market Cap

22.5B

Sector

Technology

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$147.08

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LDOS
RVMD
Founded
1969
2014
Country
United States
United States
Employees
47000
883
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5B
19.2B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
LDOS
RVMD
Price
$149.14
$147.08
Analyst Decision
Buy
Strong Buy
Analyst Count
13
19
Target Price
$203.15
$140.84
AVG Volume (30 Days)
708.9K
3.8M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.18%
N/A
EPS Growth
20.82
N/A
EPS
11.14
N/A
Revenue
$17,174,000,000.00
N/A
Revenue This Year
$6.50
N/A
Revenue Next Year
$4.40
$533.02
P/E Ratio
$13.39
N/A
Revenue Growth
3.07
N/A
52 Week Low
$139.69
$34.00
52 Week High
$205.77
$155.70

Technical Indicators

Market Signals
Indicator
LDOS
RVMD
Relative Strength Index (RSI) 39.13 64.70
Support Level N/A $93.39
Resistance Level $161.39 $155.70
Average True Range (ATR) 3.71 7.32
MACD 0.30 -0.47
Stochastic Oscillator 33.12 64.71

Price Performance

Historical Comparison
LDOS
RVMD

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health management, both domestically and internationally. The customers of the company includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: